相关实验视频
Updated: Jun 17, 2025

08:10
The 6-hydroxydopamine Rat Model of Parkinson's Disease
Published on: October 27, 2021
10.6K
在全身麻醉期间的帕金森症-过热症综合征:一个病例报告
Yoshiyuki Hiramoto1, Shinji Takahashi
1From the Department of Anesthesiology and Pain Medicine, School of Medicine, Urayasu Hospital, Juntendo University, Urayasu, Chiba, Japan.
A&A practice
|August 13, 2024
概括
帕金森症候群 (PHS) 是帕金森病 (PD) 的罕见并发症,当药物停止时可能发生. 这份报告详细介绍了第一个在全身麻醉期间的已知PHS病例,强调了外科手术期间的风险.
科学领域:
- 麻醉学 麻醉学
- 神经学 神经学
- 临界护理医学 临界护理医学
背景情况:
- 帕金森症-过热症综合征 (PHS) 是一种与帕金森病 (PD) 相关的罕见但致命的并发症.
- PHS通常发生在突然停止或减少服用抗帕金森症药物后.
- 在PD患者的麻醉管理需要仔细考虑PHS风险.
相关概念视频
General Anesthesia: Overview
199
Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
199
Stages of General Anesthesia
392
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
392
Parkinson's Disease: Treatment
240
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
240
Parkinson's Disease: Overview
501
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
501
Depolarizing Blockers: Pharmocokinetics
316
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
316
Skeletal Muscle Relaxants: Adverse Effects
349
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
349

